3/25
08:00 am
prqr
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
Medium
Report
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
3/18
03:18 pm
prqr
ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
Low
Report
ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
3/12
10:14 am
prqr
ProQR Therapeutics (PRQR) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $9.00 price target on the stock.
Medium
Report
ProQR Therapeutics (PRQR) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $9.00 price target on the stock.
3/12
07:08 am
prqr
ProQR Announces Year End 2025 Operating and Financial Results [Yahoo! Finance]
Medium
Report
ProQR Announces Year End 2025 Operating and Financial Results [Yahoo! Finance]
3/12
07:00 am
prqr
ProQR Announces Year End 2025 Operating and Financial Results
Medium
Report
ProQR Announces Year End 2025 Operating and Financial Results
3/6
06:25 pm
prqr
Faron Pharmaceuticals Oy (FPHAF) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Faron Pharmaceuticals Oy (FPHAF) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/3
05:00 pm
prqr
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference [Yahoo! Finance]
High
Report
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference [Yahoo! Finance]
3/3
04:30 pm
prqr
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
High
Report
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
2/9
08:00 am
prqr
ProQR Announces Planned Changes to Board Composition
Low
Report
ProQR Announces Planned Changes to Board Composition
1/8
08:00 am
prqr
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
Medium
Report
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
12/28
04:01 pm
prqr
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are individual investors with 34% stake, while 29% is held by institutions [Yahoo! Finance]
Medium
Report
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are individual investors with 34% stake, while 29% is held by institutions [Yahoo! Finance]